The pharmaceutical company insists it is not seeking the withdrawal of “Comarty,” the trade name of the coronavirus vaccine developed by Pfizer and BioNTech, or compensation for sales in the 92 countries where the COVAX program has agreed to help distribute the vaccine.
the pharmaceutical modern filed a complaint against the companies Pfizer and BioNtechaccusing it of violating the mRNA patent the company filed between 2010 and 2016 as part of the development of mRNA technology, used in the recent covid-19 vaccine.
“We filed these lawsuits over the innovative platform of RNA technologym that we pioneered, spent billions of dollars creating and patented during the decade before the covid-19 pandemicModerna CEO Stéphane Bancel said in a statement today.
According to Moderna, U.S. Pfizer and Germany’s BioNtech, which developed their own vaccine against the coronavirus, also using mRNA technology, “illegally copied Moderna’s inventions and continued to use them without permission,” the legal director of the company said. pharmaceutical company Shannon Thyme. klinger.
“Moderna believes that Pfizer and BioNTech have copied two key features of Moderna’s proprietary technologies that are critical to the success of mRNA vaccines,” the statement released Friday said, stating that both companies lacked the level of expertise needed for the development of vaccines based on mRNA technology when the coronavirus pandemic broke out in 2019.
The Massachusetts-based company (United States) states that in October 2020 it promised not to claim its patent rights related to Covid-19 as long as the pandemic continued.
However, he insists that in March 2022 has updated this commitment and ensured that no claim is required in the 92 countries considered low and middle-income by the World Health Organization’s COVAX program and the GAVI Foundation.
In the note, Moderna states that, as of March of this year, “as the collective fight against Covid-19 entered a new phase and the supply of vaccines in many parts of the world was no longer a barrier to entry,” the company “hoped that companies like Pfizer and BioNTech would respect their intellectual property rights and consider a commercially reasonable license if it applied for other markets.”
Moderna emphasizes that with its indictment does not request the withdrawal of “Comarty”trade name of the coronavirus vaccine developed by Pfizer and BioNTech or reimbursement for sale in the 92 countries where the COVAX program has committed to assist in the distribution of the vaccine.
Likewise, it specifies that its claims are limited to the period after March 2022.
The company, which says it has filed complaints in the United States and Germany, has not provided details about the financial compensation it is demanding from both companies.
(function(d, s, id) {
var js, fjs = d.getElementsByTagName(s)[0];
if (d.getElementById(id)) return;
js = d.createElement(s); js.id = id;
js.src = “//connect.facebook.net/es_ES/sdk.js#xfbml=1&version=v2.8”;
fjs.parentNode.insertBefore(js, fjs);
}(document, ‘script’, ‘facebook-jssdk’));
Source: EITB
I’m Wayne Wickman, a professional journalist and author for Today Times Live. My specialty is covering global news and current events, offering readers a unique perspective on the world’s most pressing issues. I’m passionate about storytelling and helping people stay informed on the goings-on of our planet.
